Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Hyseq presents gene product with potential application to vaccine development

Dec. 28, 1998

Disposition of L-732351, a semisynthetic macrolide immunosuppressant, in animals

Dec. 23, 1998

FDA approves first Lyme disease vaccine

Dec. 22, 1998

Abgenix completes phase II clinical trial in GVHD

Dec. 22, 1998

Abgenix and RCT enter CD45RB antibody collaboration

Dec. 21, 1998

Novartis updates status of immunosuppressive agent

Dec. 17, 1998

SmithKline Beecham and Ribi announce positive HBV phase III trial data

Dec. 16, 1998

MedImmune and BioTransplant initiate two new clinical studies of MEDI-507

Dec. 16, 1998

Vanguard Medica takes on development of imiquimod analogue

Dec. 15, 1998

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Dec. 15, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...